|
|
|
|
This study assessing a tryptophan-exposed population found those persons who developed EMS during the 1989 epidemic were at increased risk for death,particularly early after disease onset.Survivors reported improvement or resolution of major symptoms,suggesting that the severity of EMS diminishes with time.We found no evidence of delayed onset of EMS in tryptophan users who were not ill in 1989,regardless of the brand used. |
|